Aggressive Non-Hodgkin Lymphoma | Prior Therapy
Item
aggressive b-cell non-hodgkin's lymphoma patients with prior therapy who satisfy the conditions listed below. no restrictions regarding gender.
boolean
C1332225 (UMLS CUI [1])
C1514463 (UMLS CUI [2])
B-Cell Lymphoma CD20 positive
Item
patients with the following histologically confirmed cd20(+) b-cell non-hodgkin's lymphoma:
boolean
C0079731 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
Diffuse Large B-Cell Lymphoma
Item
1. diffuse large b-cell lymphoma
boolean
C0079744 (UMLS CUI [1])
Mantle cell lymphoma
Item
2. mantle cell lymphoma
boolean
C0334634 (UMLS CUI [1])
Transformation Lymphoma
Item
3. transformed lymphoma
boolean
C0040682 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
Follicular Lymphoma Ann Arbor lymphoma staging system
Item
4. follicular lymphoma (grade 3)
boolean
C0024301 (UMLS CUI [1,1])
C0432516 (UMLS CUI [1,2])
Complete remission failed Prior Chemotherapy | Recurrent disease Post Complete remission | Recurrent disease Post Partial response
Item
fail to cr in prior chemotherapy, or relapse following cr or recurrence following pr.
boolean
C0677874 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C1514457 (UMLS CUI [1,3])
C0277556 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C0677874 (UMLS CUI [2,3])
C0277556 (UMLS CUI [3,1])
C0687676 (UMLS CUI [3,2])
C1521726 (UMLS CUI [3,3])
Absence Effect Due to Prior Therapy | Chemotherapy | Antibody therapy | Therapeutic radiology procedure
Item
patients who are judged to carry no effect from the prior therapy (cancer chemotherapy, antibody therapy and radiation/ radiotherapy.
boolean
C0332197 (UMLS CUI [1,1])
C1280500 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C1514463 (UMLS CUI [1,4])
C0392920 (UMLS CUI [2])
C0281176 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
Age
Item
patients aged from 20 to 75 years at the time informed consent is obtained
boolean
C0001779 (UMLS CUI [1])
Organ function | Bone Marrow function | Cardiac function | Pulmonary function | Liver function | Renal function
Item
patients with adequately maintained organ functions (e.g., bone marrow, heart, lung, liver, and kidney functions)
boolean
C0678852 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
C0232164 (UMLS CUI [3])
C0231921 (UMLS CUI [4])
C0232741 (UMLS CUI [5])
C0232804 (UMLS CUI [6])
Hospitalization Possible
Item
patients who can be hospitalized during the first cycle
boolean
C0019993 (UMLS CUI [1,1])
C0332149 (UMLS CUI [1,2])
Informed Consent
Item
patients capable of personally giving voluntary informed consent in writing to participate in the study
boolean
C0021430 (UMLS CUI [1])
Criteria Fulfill
Item
patients who meet any of the following criteria will be excluded.
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Complications Serious | Liver Failure | Kidney Failure
Item
patients with serious complications (hepatic or renal failure)
boolean
C0009566 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0085605 (UMLS CUI [2])
C0035078 (UMLS CUI [3])
Complications Heart Disease Serious | Heart Disease Serious | Myocardial Infarction | Myocardial Ischemia
Item
patients with complications or medical history of serious cardiac disease (e.g., myocardial infarction, ischemic heart disease)
boolean
C0009566 (UMLS CUI [1,1])
C0018799 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0018799 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0027051 (UMLS CUI [3])
C0151744 (UMLS CUI [4])
Gastrointestinal symptom Serious | Nausea Severe | Vomiting Severe | Severe diarrhea
Item
patients with serious gastrointestinal symptoms (e.g., severe nausea, vomiting, or diarrhea)
boolean
C0426576 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0027497 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0042963 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C1443924 (UMLS CUI [4])
Hepatitis B surface antigen positive | Hepatitis C antibody positive | HIV antibody positive
Item
patients positive for hbs antigen, hcv antibody, or hiv antibody
boolean
C0149709 (UMLS CUI [1])
C0281863 (UMLS CUI [2])
C0920548 (UMLS CUI [3])
Investigational New Drugs | Drugs, Non-Prescription
Item
patients who received other investigational drug or unapproved medication within 3 months before registration in this study
boolean
C0013230 (UMLS CUI [1])
C0013231 (UMLS CUI [2])
Hematopoietic stem cell transplantation | Radioimmunotherapy
Item
patients who had history of hematopoietic stem cell transplantation or radioimmunotherapy
boolean
C0472699 (UMLS CUI [1])
C0085101 (UMLS CUI [2])
Pregnancy | Childbearing Potential | Breast Feeding
Item
patients who are pregnant, of childbearing potential, or lactating
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Contraceptive methods Unwilling
Item
patients, whether male or female, who do not agree to contraception
boolean
C0700589 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
Study Subject Participation Status Inappropriate
Item
patients otherwise judged by investigator or sub investigator to be unsuitable
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])